Rhythm Biosciences Limited (ASX:RHY)

Rhythm Biosciences Statistics

Total Valuation

ASX:RHY has a market cap or net worth of AUD 73.67 million. The enterprise value is 72.20 million.

Market Cap	73.67M
Enterprise Value	72.20M

Important Dates

The last earnings date was Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:RHY has 327.41 million shares outstanding. The number of shares has increased by 22.10% in one year.

Current Share Class	327.41M
Shares Outstanding	327.41M
Shares Change (YoY)	+22.10%
Shares Change (QoQ)	+12.61%
Owned by Insiders (%)	16.17%
Owned by Institutions (%)	7.58%
Float	228.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	44.71
PB Ratio	34.37
P/TBV Ratio	56.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.82
EV / Sales	43.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.76

Financial Position

The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.12.

Current Ratio	2.31
Quick Ratio	1.90
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	-84.48

Financial Efficiency

Return on equity (ROE) is -190.14% and return on invested capital (ROIC) is -110.90%.

Return on Equity (ROE)	-190.14%
Return on Assets (ROA)	-91.40%
Return on Invested Capital (ROIC)	-110.90%
Return on Capital Employed (ROCE)	-306.15%
Weighted Average Cost of Capital (WACC)	6.00%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.36
Inventory Turnover	7.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +126.80% in the last 52 weeks. The beta is 0.31, so ASX:RHY's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+126.80%
50-Day Moving Average	0.16
200-Day Moving Average	0.10
Relative Strength Index (RSI)	57.93
Average Volume (20 Days)	1,503,669

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:RHY had revenue of AUD 1.65 million and -6.68 million in losses. Loss per share was -0.02.

Revenue	1.65M
Gross Profit	1.01M
Operating Income	-6.60M
Pretax Income	-6.68M
Net Income	-6.68M
EBITDA	-6.40M
EBIT	-6.60M
Loss Per Share	-0.02

Balance Sheet

The company has 1.73 million in cash and 262,444 in debt, with a net cash position of 1.47 million or 0.00 per share.

Cash & Cash Equivalents	1.73M
Total Debt	262,444
Net Cash	1.47M
Net Cash Per Share	0.00
Equity (Book Value)	2.14M
Book Value Per Share	0.01
Working Capital	1.23M

Cash Flow

In the last 12 months, operating cash flow was -6.11 million and capital expenditures -24,227, giving a free cash flow of -6.14 million.

Operating Cash Flow	-6.11M
Capital Expenditures	-24,227
Free Cash Flow	-6.14M
FCF Per Share	-0.02

Margins

Gross Margin	61.47%
Operating Margin	-400.74%
Pretax Margin	-405.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:RHY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.10%
Shareholder Yield	-22.10%
Earnings Yield	-9.06%
FCF Yield	-8.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:RHY has an Altman Z-Score of -10.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.81
Piotroski F-Score	2